Name:
Pararosaniline Chloride (0.2% in .1M Hydrochloric Acid)
Synonym:
Basic Red 9; Magenta; Solvent Red 41; C.I. 4250
Section 1 - Chemical Product
MSDS Name:Pararosaniline Chloride (0.2% in .1M Hydrochloric Acid)
Synonym:Basic Red 9; Magenta; Solvent Red 41; C.I. 4250
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 569-61-9 | Pararosaniline Chloride | 0.2% | 209-321-2 |
Hazard Symbols: XN Risk Phrases: 33 |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Danger of cumulative effects.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May cause skin sensitization, an allergic reaction, which becomes evident upon re-exposure to this material.
Ingestion:
May cause effects similar to those for inhalation exposure.
Inhalation:
May cause respiratory tract irritation. May cause methemoglobinemia, cyanosis (bluish discoloration of skin due to deficient oxygenation of the blood), convulsions, tachycardia, dyspnea (labored breathing), and death. May cause anemia.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Chronic exposure can affect thyroid function. May cause pituitary gland abnormalities.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Absorption of this product into the body may cause cyanosis (bluish discoloration of skin due to deficient oxygenation of the blood).
Moderate degrees of cyanosis need to be treated only by supportive measures: bed rest and oxygen inhalation. For methemoglobinemia, administer oxygen alone or with Methylene Blue depending on the methemoglobin concentration in the blood. Cleansing of the entire contaminated area of the body is of utmost importance.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Dusts at sufficient concentrations can form explosive mixtures with air. Combustion generates toxic fumes.
Extinguishing Media:
Use carbon dioxide or dry chemical.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions.
Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. May form flammable dust-air mixtures. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 569-61-9: CAS# 7647-01-0: United Kingdom, WEL - TWA: 1 ppm TWA (aerosol mist and gas); 2 mg TWA (aerosol mist and gas) United Kingdom, WEL - STEL: 5 ppm STEL (aerosol mist and gas); 8 mg/m3 STEL (aerosol mist and gas) United States OSHA: ; 5 ppm Ceiling; 7 mg/m3 Ceiling Belgium - TWA: 5 ppm VLE; 8 mg/m3 VLE Belgium - STEL: 10 ppm VLE; 15 mg/m3 VLE France - VLE: 5 ppm VLE; 7.5 mg/m3 VLE Germany: 8 mg/m3 TWA Japan: 5 ppm Ceiling; 7.5 mg/m3 Ceiling Malaysia: 5 ppm Ceiling; 7.5 mg/m3 Ceiling Netherlands: 10 ppm STEL; 15 mg/m3 STEL Netherlands: 5 ppm MAC; 8 mg/m3 MAC Russia: 5 mg/m3 TWA Spain: 5 ppm VLA-ED; 7.6 mg/m3 VLA-ED Spain: 10 ppm VLA-EC; 15 mg/m3 VLA-EC Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Liquid
Color: dark brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C19H18ClN3
Molecular Weight: 323.82
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Decomposes when heated.
Conditions to Avoid:
Incompatible materials, temperatures above 200C.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 569-61-9: CX9850100 CAS# 7647-01-0: MW4025000 MW4031000 LD50/LC50:
CAS# 569-61-9: Oral, mouse: LD50 = 5 gm/kg.
CAS# 7647-01-0: Inhalation, mouse: LC50 = 1108 ppm/1H; Inhalation, mouse: LC50 = 20487 mg/m3/5M; Inhalation, mouse: LC50 = 3940 mg/m3/30M; Inhalation, mouse: LC50 = 8300 mg/m3/30M; Inhalation, rat: LC50 = 3124 ppm/1H; Inhalation, rat: LC50 = 60938 mg/m3/5M; Inhalation, rat: LC50 = 7004 mg/m3/30M; Inhalation, rat: LC50 = 45000 mg/m3/5M; Inhalation, rat: LC50 = 8300 mg/m3/30M; Oral, rabbit: LD50 = 900 mg/kg.
Carcinogenicity:
Pararosaniline Chloride - California: carcinogen, initial date 7/1/89 NTP: Suspect carcinogen IARC: Group 2B carcinogen Hydrochloric Acid, .1M - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
Other No information available.
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
USA RQ: CAS# 7647-01-0: 5000 lb final RQ; 2270 kg final RQ
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 33 Danger of cumulative effects.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 569-61-9: 3
CAS# 7647-01-0: 1
Canada
CAS# 569-61-9 is listed on Canadas DSL List.
CAS# 7647-01-0 is listed on Canadas DSL List.
CAS# 569-61-9 is listed on Canadas Ingredient Disclosure List.
CAS# 7647-01-0 is listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 569-61-9 is listed on the TSCA inventory.
CAS# 7647-01-0 is listed on the TSCA inventory.